血液透析患者的血压靶目标值研究进展  

Progress of research on target value of blood pressure in patients undergoing hemodialysis

作　　者：李晓晨 乔晞[1] Xiaochen Li;Xi Qiao(Department of Nephrology,Second Hospital of Shanxi Medical University,Shanxi Provincial Institute for Kidney Disease,Kidney Disease Institute of Shanxi Medical University,Taiyuan 030001,Shanxi Province,China)

机构地区：[1]山西医科大学第二医院、山西省肾脏病研究所、山西医科大学肾脏病研究所,太原030001

出　　处：《中华肾病研究电子杂志》2023年第3期168-171,共4页Chinese Journal of Kidney Disease Investigation（Electronic Edition）

基　　金：山西省回国留学人员科研资助项目(2020-186);山西省留学回国人员科技活动择优资助项目(2017-29)。

摘　　要：血液透析(HD)是目前全球范围内使用最为普遍的肾脏替代治疗方式。HD患者死亡的首要原因是心血管系统疾病,而后者与患者血压水平密切相关。因此,血压控制非常重要。目前国内外对HD患者血压管理的靶目标值尚未有统一的意见。本文就HD患者血压管理的靶目标值与临床预后之间的关系研究进展进行了综述。Hemodialysis(HD)is the most widely used renal replacement therapy in the world.The first cause of death in HD patients is cardiovascular disease,which is closely related to the blood pressure.Blood pressure control is very important.At present,there is no unified opinion on the target value of blood pressure management in HD patients in the world.This article reviewed the progress of research on relationship between target value of blood pressure management and clinical prognosis in HD patients.

关 键 词：高血压 靶目标值 预后 

分 类 号：R692.5[医药卫生—泌尿科学]